Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence

The therapeutic concept of unleashing a pre-existing immune response against the tumor by the application of immune-checkpoint inhibitors (ICI) has resulted in long-term survival in advanced cancer patient subgroups. However, the majority of patients do not benefit from single-agent ICI and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Leisch, Michael, Geisberger, Roland, Melchardt, Thomas, Rinnerthaler, Gabriel, Zaborsky, Nadja, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215892/
https://www.ncbi.nlm.nih.gov/pubmed/32325898
http://dx.doi.org/10.3390/ijms21082856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215892/
https://www.ncbi.nlm.nih.gov/pubmed/32325898
http://dx.doi.org/10.3390/ijms21082856

Ejemplares similares